当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析

睿智医药

(300149)

  

流通市值:33.03亿  总市值:33.09亿
流通股本:4.99亿   总股本:5.00亿

睿智医药(300149)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.62亿元,每股收益-0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益138966.93万元,未分配利润-51576.39万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产215664.85万元,负债76697.92万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入718,525,731.65465,164,579.93234,594,741.641,138,365,803
营业总成本774,216,447.7525,102,424.42263,463,408.411,198,434,734.47
营业利润-66,557,761.02-69,672,275.36-27,268,564.97-936,363,721.9
利润总额-67,038,704.04-70,057,447.06-27,440,132.91-939,765,940.3
净利润-61,782,349.49-62,980,202.1-25,499,750.88-916,938,966.44
其他综合收益-9,433,940.61-1,144,800.811,875,939.77,823,267.39
综合收益总额-71,216,290.1-64,125,002.91-23,623,811.18-909,115,699.05
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计623,951,592615,056,179.17676,526,244.27727,179,070.94
非流动资产合计1,532,696,9361,639,791,860.741,669,887,918.871,707,143,859.18
资产总计2,156,648,5282,254,848,039.912,346,414,163.142,434,322,930.12
流动负债合计347,226,879.58360,464,093.76384,931,622.86426,774,745.76
非流动负债合计419,752,330.52497,623,341.06524,220,743.46546,662,576.36
负债合计766,979,210.1858,087,434.82909,152,366.32973,437,322.12
归属于母公司股东权益合计1,365,545,650.891,372,595,306.311,413,061,988.91,436,646,599.86
股东权益合计1,389,669,317.91,396,760,605.091,437,261,796.821,460,885,608
负债和股东权益合计2,156,648,5282,254,848,039.912,346,414,163.142,434,322,930.12
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计788,197,815.19533,647,375.72267,606,773.941,313,071,840.01
经营活动现金流出小计675,652,696.34462,584,127.61242,373,085.641,162,079,525.18
经营活动产生的现金流量净额112,545,118.8571,063,248.1125,233,688.3150,992,314.83
投资活动现金流入小计5,806,006.035,644,307.312,511,697.69587,849,982.78
投资活动现金流出小计64,233,346.9753,622,037.9635,216,989.54600,670,352.45
投资活动产生的现金流量净额-58,427,340.94-47,977,730.65-32,705,291.85-12,820,369.67
筹资活动现金流入小计28,450,00018,450,000-107,954,916
筹资活动现金流出小计109,664,255.9880,464,868.0211,828,622.33496,296,231.4
筹资活动产生的现金流量净额-81,214,255.98-62,014,868.02-11,828,622.33-388,341,315.4
汇率变动对现金及现金等价物的影响-1,598,568.527,911,685.013,073,804.446,975,104.05
现金及现金等价物净增加额-28,695,046.59-31,017,665.55-16,226,421.44-243,194,266.19
期末现金及现金等价物余额313,534,328.62311,211,709.66326,002,953.77342,229,375.21
TOP↑